A Safety and Efficacy Study of CC-90009 Combinations in Subjects With Acute Myeloid Leukemia
Status:
Suspended
Trial end date:
2024-10-17
Target enrollment:
Participant gender:
Summary
CC-90009-AML-002 is an exploratory Phase 1b open-label multi-arm trial to evaluate the safety
and efficacy of CC-90009 in combination with anti-leukemia agents in subjects with acute
myeloid leukemia (AML).